{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-045194","form_type":"8-K","ticker":"CCCC","cik":"0001662579","company_name":"C4 Therapeutics, Inc.","filed_at":"2026-06-24T20:22:04+00:00","discovered_at":"2026-06-24T20:23:00.214063+00:00","generated_at":"2026-06-24T20:23:48.911282+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"C4 Therapeutics stockholders elect directors, approve equity plan amendment including pre-funded warrants","bullets":["Three Class III directors (Hirsch, Fawell, Koppikar) re-elected with 47.8M–46.5M votes for each.","Non-binding advisory vote on executive compensation approved: 54.9M for, 1.07M against.","Stockholders ratified KPMG as independent auditor for fiscal 2026 with 76.9M votes in favor.","Amendment to 2020 Stock Plan approved: includes pre-funded warrants in Outstanding Shares definition for evergreen increase calculation."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-045194","json":"https://secwatch.observer/filing/0001628280-26-045194.json","markdown":"https://secwatch.observer/filing/0001628280-26-045194.md","text":"https://secwatch.observer/filing/0001628280-26-045194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662579/000162828026045194/0001628280-26-045194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662579/000162828026045194/cccc-20260624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:23:48.911282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}